ProfileGDS4132 / 212902_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 30% 24% 24% 27% 27% 28% 31% 22% 25% 26% 24% 21% 22% 22% 25% 22% 24% 19% 25% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10187.372534
GSM201543Muscle PCOS pioglitazone 12164.090930
GSM201544Muscle PCOS pioglitazone 16160.108524
GSM201545Muscle PCOS pioglitazone 20162.647924
GSM201829Muscle PCOS pioglitazone 23169.674327
GSM201830Muscle PCOS pioglitazon 25166.17427
GSM201831Muscle PCOS pioglitazone 27166.757328
GSM201832Muscle PCOS pioglitazone 3176.066131
GSM201833Muscle PCOS pioglitazone 4147.968522
GSM201834Muscle PCOS pioglitazone 8156.273225
GSM201835Muscle PCOS after pioglitazone 10249.195726
GSM201836Muscle PCOS after pioglitazone 12246.779824
GSM201837Muscle PCOS after pioglitazone 16236.890721
GSM201838Muscle PCOS after pioglitazone 20244.108722
GSM201839Muscle PCOS after pioglitazone 23243.476922
GSM201840Muscle PCOS after pioglitazone 25256.152325
GSM201841Muscle PCOS after pioglitazone 27239.339222
GSM201842Muscle PCOS after pioglitazone 3243.324424
GSM201843Muscle PCOS after pioglitazone 4240.747519
GSM201844Muscle PCOS after pioglitazone 8253.669625